Emergent BioSolutions Inc. announced that the company will be added to the broad-market Russell 3000 Index, effective after the U.S. market closes on June 27, 2025. This inclusion is part of the annual reconstitution of the Russell U.S. stock indexes.
Membership in the Russell 3000 Index automatically includes Emergent in either the large-cap Russell 1000 Index or small-cap Russell 2000 Index, as well as the appropriate growth and value style indexes. This move is expected to increase the company's visibility within the investment community.
The Russell indexes are widely utilized by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. This recognition reflects the positive momentum Emergent is building across its organization and supports its new phase of disciplined, sustainable growth.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.